Microsoft sinks deeper into drug AI, inks collab with diabetes giant Novo Nordisk
It now appears that Microsoft wants to take on diabetes.
In its latest foray into the drugmaking world, the tech giant has signed a five …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
